Kidney Transplant Rejection Therapeutics Market

List of Tables
Table 1. Kidney Transplant Rejection Therapeutics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Kidney Transplant Rejection Therapeutics Market Trends
Table 3. Kidney Transplant Rejection Therapeutics Market Drivers
Table 4. Kidney Transplant Rejection Therapeutics Market Challenges
Table 5. Kidney Transplant Rejection Therapeutics Market Restraints
Table 6. Global Kidney Transplant Rejection Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Kidney Transplant Rejection Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Kidney Transplant Rejection Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Kidney Transplant Rejection Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Kidney Transplant Rejection Therapeutics Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Kidney Transplant Rejection Therapeutics Revenue Share by Manufacturer, 2017-2022
Table 13. Global Kidney Transplant Rejection Therapeutics Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Kidney Transplant Rejection Therapeutics Sales Share by Manufacturer, 2017-2022
Table 15. Global Kidney Transplant Rejection Therapeutics Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Kidney Transplant Rejection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Kidney Transplant Rejection Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Transplant Rejection Therapeutics as of 2021)
Table 18. Top Players of Kidney Transplant Rejection Therapeutics in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Kidney Transplant Rejection Therapeutics Product Type
Table 20. Date of International Manufacturers Enter into Kidney Transplant Rejection Therapeutics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Kidney Transplant Rejection Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Kidney Transplant Rejection Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Kidney Transplant Rejection Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Kidney Transplant Rejection Therapeutics Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Kidney Transplant Rejection Therapeutics Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Kidney Transplant Rejection Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Kidney Transplant Rejection Therapeutics Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Kidney Transplant Rejection Therapeutics Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Kidney Transplant Rejection Therapeutics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Kidney Transplant Rejection Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Kidney Transplant Rejection Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Kidney Transplant Rejection Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Kidney Transplant Rejection Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Kidney Transplant Rejection Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CSL Limited Corporation Information
Table 43. CSL Limited Description and Business Overview
Table 44. CSL Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. CSL Limited Kidney Transplant Rejection Therapeutics Product
Table 46. CSL Limited Recent Development
Table 47. Digna Biotech, S.L. Corporation Information
Table 48. Digna Biotech, S.L. Description and Business Overview
Table 49. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Digna Biotech, S.L. Product
Table 51. Digna Biotech, S.L. Recent Development
Table 52. GlaxoSmithKline Plc Corporation Information
Table 53. GlaxoSmithKline Plc Description and Business Overview
Table 54. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. GlaxoSmithKline Plc Product
Table 56. GlaxoSmithKline Plc Recent Development
Table 57. Grifols, S.A. Corporation Information
Table 58. Grifols, S.A. Description and Business Overview
Table 59. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Grifols, S.A. Product
Table 61. Grifols, S.A. Recent Development
Table 62. Hansa Medical AB Corporation Information
Table 63. Hansa Medical AB Description and Business Overview
Table 64. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Hansa Medical AB Product
Table 66. Hansa Medical AB Recent Development
Table 67. Kyowa Hakko Kirin Corporation Information
Table 68. Kyowa Hakko Kirin Description and Business Overview
Table 69. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Kyowa Hakko Kirin Product
Table 71. Kyowa Hakko Kirin Recent Development
Table 72. Mabtech Limited Corporation Information
Table 73. Mabtech Limited Description and Business Overview
Table 74. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Mabtech Limited Product
Table 76. Mabtech Limited Recent Development
Table 77. Magnus Life Ltd Corporation Information
Table 78. Magnus Life Ltd Description and Business Overview
Table 79. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Magnus Life Ltd Product
Table 81. Magnus Life Ltd Recent Development
Table 82. Noorik Biopharmaceuticals AG Corporation Information
Table 83. Noorik Biopharmaceuticals AG Description and Business Overview
Table 84. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Noorik Biopharmaceuticals AG Product
Table 86. Noorik Biopharmaceuticals AG Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. Opsona Therapeutics Limited Corporation Information
Table 93. Opsona Therapeutics Limited Description and Business Overview
Table 94. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Opsona Therapeutics Limited Product
Table 96. Opsona Therapeutics Limited Recent Development
Table 97. OSE Immunotherapeutics Corporation Information
Table 98. OSE Immunotherapeutics Description and Business Overview
Table 99. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. OSE Immunotherapeutics Product
Table 101. OSE Immunotherapeutics Recent Development
Table 102. Pharmicell Corporation Information
Table 103. Pharmicell Description and Business Overview
Table 104. Pharmicell Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Pharmicell Product
Table 106. Pharmicell Recent Development
Table 107. Pharming Group N.V. Corporation Information
Table 108. Pharming Group N.V. Description and Business Overview
Table 109. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Pharming Group N.V. Product
Table 111. Pharming Group N.V. Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Kidney Transplant Rejection Therapeutics Customers List
Table 115. Kidney Transplant Rejection Therapeutics Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Transplant Rejection Therapeutics Product Picture
Figure 2. Global Kidney Transplant Rejection Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Kidney Transplant Rejection Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. Global Kidney Transplant Rejection Therapeutics Sales 2017-2028 (K Pcs)
Figure 5. United States Kidney Transplant Rejection Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Kidney Transplant Rejection Therapeutics Market Size 2017-2028 (US$ Million)
Figure 7. United States Kidney Transplant Rejection Therapeutics Sales 2017-2028 (K Pcs)
Figure 8. United States Kidney Transplant Rejection Therapeutics Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Kidney Transplant Rejection Therapeutics Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Kidney Transplant Rejection Therapeutics Report Years Considered
Figure 11. Product Picture of Azathioprine
Figure 12. Product Picture of Cortina
Figure 13. Product Picture of Cyclophosphamide
Figure 14. Product Picture of Cyclosporin A
Figure 15. Product Picture of Other
Figure 16. Global Kidney Transplant Rejection Therapeutics Market Share by Type in 2022 & 2028
Figure 17. Global Kidney Transplant Rejection Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Kidney Transplant Rejection Therapeutics Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Kidney Transplant Rejection Therapeutics Market Share by Type in 2022 & 2028
Figure 23. United States Kidney Transplant Rejection Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Kidney Transplant Rejection Therapeutics Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Hospital
Figure 29. Product Picture of Clinic
Figure 30. Product Picture of ASCs
Figure 31. Product Picture of Others
Figure 32. Global Kidney Transplant Rejection Therapeutics Market Share by Application in 2022 & 2028
Figure 33. Global Kidney Transplant Rejection Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028) & (K Pcs)
Figure 36. Global Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Kidney Transplant Rejection Therapeutics Price by Application (2017-2028) & (USD/Pcs)
Figure 38. United States Kidney Transplant Rejection Therapeutics Market Share by Application in 2022 & 2028
Figure 39. United States Kidney Transplant Rejection Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Kidney Transplant Rejection Therapeutics Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028) & (K Pcs)
Figure 42. United States Kidney Transplant Rejection Therapeutics Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Kidney Transplant Rejection Therapeutics Price by Application (2017-2028) & (USD/Pcs)
Figure 44. North America Kidney Transplant Rejection Therapeutics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. North America Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Kidney Transplant Rejection Therapeutics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 49. Europe Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 56. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Kidney Transplant Rejection Therapeutics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 68. Latin America Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 73. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. UAE Kidney Transplant Rejection Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Kidney Transplant Rejection Therapeutics Value Chain
Figure 78. Kidney Transplant Rejection Therapeutics Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed